abstract |
The invention relates to novel compounds of formula (I) which are biologically active as alpha v beta 3 integrin ligands X-Y-Z-R<1>-CH2-R<2>(R<4>)-CH2-CO-R<5>, whereby X, Y, Z, R<1>, R<2>, R<4> and R<5> have meanings cited in Claim (1). The invention also relates to the physiologically acceptable salts and solvates thereof. |